Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BELLERGAL SPACETABS 0.6 MG

ERGOTAMINE TARTRATE : 0.6 MG BELLADONNA : 0.2 MG PHENOBARBITAL : 40.0 MG · DIN 00176141 · PALADIN PHARMA INC.

Health Canada status: CANCELLED POST MARKET

What is BELLERGAL SPACETABS?

BELLERGAL SPACETABS 0.6 MG contains ERGOTAMINE TARTRATE : 0.6 MG BELLADONNA : 0.2 MG PHENOBARBITAL : 40.0 MG. It is listed in the Health Canada Drug Product Database under DIN 00176141, held by PALADIN PHARMA INC., supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 05-Jun-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is BELLERGAL SPACETABS used for?

Functional symptoms associated with menopause, such as hot flushes, perspiration, palpitations, dizzy spells, restlessness, apprehension, fatigue, insomnia, and headache.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN00176141
Brand nameBELLERGAL SPACETABS
Generic / active ingredientERGOTAMINE TARTRATE : 0.6 MG BELLADONNA : 0.2 MG PHENOBARBITAL : 40.0 MG
ManufacturerPALADIN PHARMA INC.
Strength0.6 MG
Dosage formTABLET (EXTENDED-RELEASE)
Route of administrationORAL
ScheduleCONTROLLED DRUGS (CDSA IV)
ATC codeA03ED ANTISPASMODICS IN COMBINATION WITH OTHER DRUGS
AHFS class12:08.08
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date05-Jun-2018
Original market date1959-01-01 00:00:00

How is it stored and handled?

15°C to 30°C

How is it supplied?

bottles of 10

What can be used instead?

Other Canadian products sharing ATC code A03ED ANTISPASMODICS IN COMBINATION WITH OTHER DRUGS. 0 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
BABY'S OWN GRIPE WATER.9 MG / 5 MLLIQUIDDANNORTH LABORATORIES INC.CANCELLED POST MARKETDIN 02021781
BABY'S OWN GRIPE WATER - LIQ1.8 MG / 5 MLLIQUIDBLOCK DRUG COMPANY (CANADA) LTD.CANCELLED POST MARKETDIN 02227525
BABYS OWN GRIPE WATER3.6 MG / 10 MLLIQUIDG.T. FULFORD PHARMACEUTICALSCANCELLED POST MARKETDIN 00402397
BELLERGAL TAB.3 MGTABLETSANDOZ CANADA INCCANCELLED POST MARKETDIN 00176133
DONNATAL ELIXIR0.1037 MG / 5 MLELIXIRAYERST LABORATORIESCANCELLED POST MARKETDIN 01909282
DONNATAL ELIXIR16.2 MG / 5 MLELIXIRWYETH-AYERST CANADA INC.CANCELLED POST MARKETDIN 02042894
DONNATAL EXTENTABS48.6 MGTABLET (EXTENDED-RELEASE)AYERST LABORATORIESCANCELLED POST MARKETDIN 01909274
DONNATAL EXTENTABS SRT0.0195 MGTABLET (EXTENDED-RELEASE)WYETH-AYERST CANADA INC.CANCELLED POST MARKETDIN 02042908
DONNATAL TAB0.0194 MGTABLETWYETH-AYERST CANADA INC.CANCELLED POST MARKETDIN 02042916
GRIPE WATERStrengthLiquidSHOPPERS DRUG MART INC. 243 Consumers Road North York (Toronto) Ontario Canada M2J 4W8CANCELLED POST MARKETDIN 00417661

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 00176141. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.